Beijing Wantai Biological Pharmacy Enterprise's (SHA:603392) net loss attributable to shareholders in the first half narrowed to 128.3 million yuan from 144 million yuan a year earlier, according to a Shanghai bourse filing on Thursday.
Loss per share was 0.10 yuan, compared to 0.11 yuan in the previous year.
Operating revenue jumped 24% year on year to 1.05 billion yuan from 843.6 million yuan.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.